本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

XORTX Therapeutics Inc.

0.8700
-0.0780-8.23%
盘后0.89080.0208+2.39%16:02 EDT
成交量:2,358.00
成交额:2,137.68
市值:329.58万
市盈率:-0.76
高:0.9480
开:0.8873
低:0.8700
收:0.9480
数据加载中...
2024/11/22

SEC问询函

Form CORRESP - Correspondence
2024/11/15

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/05/10

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/01

SEC问询函

CORRESP [Cover] - Correspondence
2023/01/27

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/10/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/22

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/22

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/21

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/21

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/09/19

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/19

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/12

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/09/08

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/08

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/08

招股说明书

F-1 - Registration statement for certain foreign private issuers